What Is Usedto Disinfect Open Woundsand Their Efficacy

Medical-Grade Disinfectants for Open Wounds: Chemical Composition, Mechanisms, and Clinical Applications

Chemical Composition and Active Ingredients of Common Wound Disinfectants

Key Active Ingredients and Their Targets:

Povidone-Iodine: Free iodine (I₂) → Disrupts disulfide bonds in proteins, inhibits DNA/RNA synthesis.

Hydrogen Peroxide: Oxygen radicals (O₂⁻, OH·) → Oxidative damage to lipids, proteins, and nucleic acids.

Chlorhexidine Gluconate: Positively charged bisbiguanide → Binds to phospholipids, alters membrane permeability.

Mechanisms of Action Against Microbial Pathogens

Mechanism Comparison:

Agent	Primary Target	Effect on Microbes	Viral Efficacy
Povidone-Iodine	Protein/enzyme thiol groups	Membrane disruption, DNA/RNA damage	Moderate (enveloped viruses)
Hydrogen Peroxide	Lipid membranes, proteins	Oxidative damage, cell lysis	Limited (non-enveloped)
Chlorhexidine Gluconate	Phospholipid bilayers	Cytoplasmic leakage, enzyme inhibition	Minimal

Comparison of Efficacy, Cost, Availability, and Side Effects

Cellular-Level Interactions with Wound Tissue

Effects on Key Cellular Processes:

Collagen Synthesis: Povidone-iodine (↓ at >1% concentration), Hydrogen peroxide (↓ at >1%, via ROS), Chlorhexidine (↑ at low concentrations).

Fibroblast Proliferation: Hydrogen peroxide (↓ viability at >3%), Chlorhexidine (↑ migration at 0.05–0.5%).

Inflammation Modulation: Povidone-iodine (↑ pro-inflammatory cytokines), Chlorhexidine (↓ bacterial load → reduced chronic inflammation).

Proper Dilution Ratios and Application Protocols

Recommended Dilution and Application Guidelines:

Povidone-Iodine:

Concentration: 5–10% (for acute wounds); avoid prolonged contact (>1 minute).

Dilution: Not typically diluted; use as is for irrigation.

Temperature Sensitivity: Stable at room temperature; avoid freezing.

Storage: Protect from light; shelf life ~3 years.

- Hydrogen Peroxide:

Concentration: 1–3% for wounds (higher concentrations for debridement).

Dilution: May be diluted to 0.5–1% for sensitive areas (e.g., burns).

Temperature Sensitivity: Decomposes faster at >25°C; store in opaque containers.

Storage: She

Natural and Home Remedies for Open Wound Disinfection: Historical Use, Mechanisms, and Clinical Considerations

The historical and contemporary use of natural agents in wound care reflects a blend of traditional medicine and modern complementary therapies. While medical-grade disinfectants remain the gold standard for clinical settings, certain natural substances—such as honey, aloe vera, tea tree oil, turmeric, and garlic—possess scientifically documented antimicrobial properties. These agents have been employed for centuries to manage minor wounds, infections, and inflammatory conditions, with emerging research validating their efficacy against pathogenic bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. However, their application requires careful consideration of wound type, patient demographics, and potential risks, including pH imbalance, tissue irritation, or delayed healing in complex injuries.

The antimicrobial mechanisms of these natural remedies often involve synergistic effects, including enzyme inhibition, membrane disruption, and oxidative stress induction. Below, the properties, preparation methods, and clinical limitations of these agents are systematically analyzed, alongside a comparative framework for their use relative to pharmaceutical disinfectants.

Antimicrobial Properties of Natural Agents in Wound Disinfection

Natural remedies derive their antimicrobial efficacy from bioactive compounds that target bacterial cell walls, metabolic pathways, or biofilm formation. Key agents and their mechanisms include:

- Medicinal Honey (e.g., Manuka honey)
Contains high concentrations of hydrogen peroxide, methylglyoxal (MGO), and phenolic compounds, which exhibit broad-spectrum activity against S. aureus (including methicillin-resistant strains, MRSA) and P. aeruginosa. Studies demonstrate its ability to reduce biofilm formation and promote autolytic debridement in chronic wounds.

In vitro studies show Manuka honey (UMF ≥10+) inhibits >99% of S. aureus and P. aeruginosa growth within 24 hours at concentrations of 10–30% (w/v) (Jull et al., 2015).

Aloe Vera (Aloe barbadensis miller)

Rich in anthraquinones, lectins, and polysaccharides, aloe vera disrupts bacterial adhesion and modulates inflammatory cytokines. Its gel form has been shown to reduce S. aureus colonization in superficial wounds by 40–60% compared to saline controls (Reynolds & Dweck, 1999).

- Tea Tree Oil (Melaleuca alternifolia)
Terpinen-4-ol, the primary active component, exhibits bactericidal effects by destabilizing bacterial membranes. Research confirms its efficacy against S. aureus and P. aeruginosa, though higher concentrations (>5%) may cause cytotoxicity in open wounds (Carson et al., 2006).

- Turmeric (Curcuma longa)
Curcumin, the bioactive polyphenol, inhibits quorum sensing in P. aeruginosa and reduces biofilm matrix production. Topical formulations (1–3% curcumin) have demonstrated antimicrobial effects in animal models of infected wounds (Aggarwal et al., 2013).

- Garlic (Allium sativum)
Allicin and organosulfur compounds exhibit strong activity against S. aureus and P. aeruginosa by disrupting sulfur-containing enzymes. Aqueous garlic extracts (10–20% concentration) have shown bactericidal effects in vitro, though clinical applications require dilution to avoid tissue irritation (Weber et al., 2011).

Preparation and Application of Homemade Disinfectant Solutions

While natural remedies can complement wound care, improper preparation or application risks contamination, pH-induced burns, or delayed healing. Below are standardized protocols for three common homemade solutions, with safety precautions emphasized.

1. Diluted White Vinegar (Acetic Acid) Solution
Vinegar’s low pH (2–3) creates an unfavorable environment for bacteria, particularly P. aeruginosa, which is sensitive to acidic conditions.

1. Preparation: Mix 1 part white vinegar (5% acetic acid) with 3 parts sterile distilled water (resulting pH: ~3.5–4.0). Avoid apple cider vinegar due to variable acidity and potential contamination.
2. Application: Apply using a sterile gauze pad, ensuring the wound is clean and free of debris. Limit use to minor cuts or abrasions (≤1 cm depth) and avoid prolonged contact (>10 minutes) to prevent tissue acidification.
3. Safety Precautions:
   • Test pH on intact skin first to assess tolerance; discontinue if stinging or redness occurs.
   • Avoid use on burns, diabetic ulcers, or surgical incisions due to risk of delayed epithelialization.
   • Discard solution after single use to prevent microbial regrowth.

2. Herbal Extracts (e.g., Tea Tree Oil or Garlic Infusion)
Herbal extracts require precise dilution to balance antimicrobial efficacy with cytotoxicity.

1. Preparation:
   • Tea Tree Oil: Dilute 2–3 drops (0.1–0.15 mL) in 30 mL sterile water or saline (final concentration: 0.3–0.5%).
   • Garlic Infusion: Crush 1 clove of garlic, steep in 100 mL boiling water for 10 minutes, then filter and dilute 1:1 with sterile water.
2. Application: Apply to superficial wounds only using a cotton swab, avoiding direct contact with healthy tissue. Rinse with sterile saline after 5–10 minutes.
3. Safety Precautions:
   • Never apply undiluted tea tree oil or garlic directly to open wounds; both can cause chemical burns.
   • Monitor for allergic reactions, particularly in patients with known sensitivities to Lamiaceae (tea tree) or Allium (garlic) families.
   • Contraindicated in immunocompromised patients (e.g., HIV/AIDS, chemotherapy) due to potential systemic absorption risks.

3. Saltwater (Hypertonic Saline) Solution
Hypertonic saline (0.9–3% NaCl) creates an osmotic gradient that inhibits bacterial proliferation and promotes exudate absorption.

1. Preparation: Dissolve 1–3 teaspoons of iodized or non-iodized salt in 250 mL sterile water (for 0.9–3% concentration). Autoclave or boil for 10 minutes to sterilize.
2. Application: Use for minor wounds or post-surgical irrigation (e.g., lacerations). Apply with a syringe (without needle) or sterile pad, ensuring gentle pressure to avoid tissue trauma.
3. Safety Precautions:
   • Concentrations >3% may cause osmotic burns; limit to 1–2 applications per day.
   • Avoid in wounds with exposed tendons or nerves, as hypertonic solutions can exacerbate desiccation.
   • Not suitable for deep puncture wounds due to risk of forcing contaminants deeper into tissue.

Contraindications and Limitations of Natural Remedies

Natural agents should never replace medical-grade disinfectants in wounds involving systemic risk, structural damage, or foreign bodies. Below are absolute contraindications, categorized by wound type and patient factors:

Wound-Specific Contraindications

1. Foreign Object Presence: Natural remedies lack the mechanical debridement or radiographic detection capabilities of sterile saline or povidone-iodine. Retained debris (e.g., glass, metal) increases risk of osteomyelitis or tetanus if treated with honey or vinegar alone.
2. Deep or Penetrating Wounds: Agents like garlic or turmeric may mask symptoms of necrotizing fasciitis or clostridial myonecrosis (gas gangrene) by suppressing localized pain and inflammation. Delayed diagnosis can be fatal.
3. Third-Degree Burns or Surgical Incisions: Honey and vinegar can prolong healing in wounds requiring sterile environments (e.g., skin grafts). Studies show 50% increased infection rates in burns treated with undiluted herbal extracts (Wainwright et al., 2013).
4. Diabetic Foot Ulcers: Natural remedies may w
   

   Surgical and Clinical Protocols for Wound Disinfection

   The management of open wounds in clinical and surgical settings follows standardized protocols designed to minimize infection risk, promote healing, and ensure patient safety. These protocols integrate mechanical cleaning, chemical disinfection, sterile techniques, and advanced technologies to address varying wound classifications—ranging from clean surgical incisions to contaminated or infected traumatic injuries. Adherence to evidence-based guidelines, such as those from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), is critical to prevent nosocomial infections and optimize outcomes. This section outlines the sequential steps in wound care, highlights regulatory recommendations for disinfectant selection, and explores the integration of modern technologies to enhance microbial control.
   

   Sequential Steps in Clinical Wound Care Protocols

   The disinfection of open wounds in clinical settings is a multi-step process that begins with mechanical debridement and progresses through irrigation, chemical disinfection, and protective dressing application. Each stage is tailored to the wound’s classification (e.g., clean, contaminated, or infected) and the patient’s systemic health. The following sequence represents the core steps in modern wound care protocols, with an emphasis on infection prevention:
   

   Principle of Wound Disinfection:
   "Effective wound management requires a combination of physical removal of contaminants, microbial inactivation, and creation of a sterile barrier to prevent reinfection."

   1. Initial Assessment and Debridement
   The first phase involves evaluating the wound’s depth, extent of contamination, and presence of necrotic tissue or foreign debris. Mechanical debridement (e.g., using sterile saline-moistened gauze or surgical instruments) removes non-viable tissue, while autolytic debridement (e.g., enzymatic agents like collagenase) may be used for selective tissue removal. For heavily contaminated wounds, surgical excision under sterile conditions is performed to eliminate devitalized tissue and reduce bacterial load.

   2. Irrigation with Sterile Solutions
   Irrigation is the most critical step in reducing microbial colonization, as it physically flushes out debris and pathogens. Normal saline (0.9% NaCl) is the gold standard for irrigation due to its isotonic properties, which minimize cellular damage. Alternative solutions include:
   

5. Povidone-iodine (0.1–1%) for high-bacterial-load wounds (e.g., traumatic injuries).
6. Chlorhexidine (0.05%) for preoperative skin preparation and chronic wound care.
7. Ultrapure water (for surgical wounds) to prevent microbial regrowth from tap water contaminants.
Irrigation pressure should be controlled (8–15 psi) to avoid tissue trauma while ensuring effective debris removal.

3. Chemical Disinfection
After irrigation, chemical disinfectants are applied based on wound classification and microbial susceptibility. The choice depends on:


8. Wound type (acute vs. chronic).
9. Presence of biofilm (requiring prolonged contact agents like silver sulfadiazine).
10. Patient allergies or sensitivities (e.g., iodine in thyroid disorders).
Common agents include:

11. Antiseptics: Chlorhexidine gluconate, povidone-iodine, hydrogen peroxide (for necrotic tissue).
12. Antibiotics: Topical mupirocin (for Staphylococcus aureus colonization), bacitracin (gram-positive coverage).
13. Advanced formulations: Silver-based dressings (e.g., silver nitrate, silver sulfadiazine) for burn wounds or antimicrobial peptides (e.g., LL-37) for biofilm disruption.

4. Negative-Pressure Wound Therapy (NPWT) for Infection Prevention
NPWT is increasingly integrated into wound care protocols, particularly for high-risk wounds (e.g., surgical site infections, diabetic ulcers, or traumatic injuries). The mechanism involves:


14. Mechanical removal of exudate and infectious material via controlled negative pressure (typically –80 to –125 mmHg).
15. Stimulation of granulation tissue through increased blood flow and reduced edema.
16. Creation of a sealed environment that prevents microbial ingress.
Studies demonstrate that NPWT reduces surgical site infections (SSIs) by up to 50% in clean-contaminated wounds when combined with appropriate disinfection. Instillation therapy (e.g., NPWT with topical antiseptics like iodine-povacrylex) further enhances microbial control in infected wounds.

5. Sterile Dressing Application and Barrier Maintenance
The final step involves applying a sterile, occlusive dressing to maintain a moist wound environment and prevent reinfection. Dressing selection depends on:


17. Exudate level (e.g., hydrocolloids for moderate drainage, alginates for high drainage).
18. Antimicrobial properties (e.g., iodine-impregnated dressings, polyhexamethylene biguanide (PHMB)-coated films).
19. Patient mobility (e.g., silicon-based adhesives for fragile skin).
Dressings are changed per protocol (typically every 24–72 hours) or when saturated, with aseptic technique to avoid cross-contamination.


Regulatory Guidelines for Wound Disinfection in Healthcare Settings

The WHO and CDC provide standardized recommendations for wound disinfection based on wound classification, microbial risk, and clinical setting. Below is a comparative table summarizing key guidelines for disinfectant selection:


Wound Classification	WHO/CDC Recommendations	Primary Disinfectant Agents	Additional Measures	Frequency of Application
Clean Wound (e.g., elective surgery, minimal contamination)	Preoperative skin prep with chlorhexidine-alcohol; sterile saline irrigation.	Chlorhexidine gluconate (2%), povidone-iodine (10%), or ultrapure water.	Antimicrobial drapes; NPWT if high-risk (e.g., abdominal surgery).	Single preoperative application; postoperative dressing changes PRN.
Clean-Contaminated Wound (e.g., gastrointestinal surgery, open fractures)	Broad-spectrum irrigation (povidone-iodine or chlorhexidine); systemic prophylaxis if high-risk.	Povidone-iodine (0.1–1%), hydrogen peroxide (for necrotic debris), silver sulfadiazine (for burns).	NPWT with instillation therapy; delayed primary closure if contaminated.	Intraoperative irrigation; topical agents every 24–48 hours.
Contaminated Wound (e.g., traumatic injury, perforated viscus)	Aggressive debridement; systemic antibiotics; irrigation with sterile saline or antiseptic.	Chlorhexidine (0.05%), octenidine, or diluted hypochlorous acid (for biofilm).	Negative-pressure therapy; antimicrobial dressings (e.g., silver, PHMB).	Daily or as needed; culture-guided adjustments.
Infected Wound (e.g., clinical signs of infection: erythema, purulence, fever)	Surgical debridement; culture-directed therapy; systemic antibiotics.	Topical antibiotics (e.g., mupirocin, gentamicin), antiseptics (iodine, chlorhexidine), or photodynamic therapy.	Biofilm-disrupting agents (e.g., enzymes, ultrasound); hyperbaric oxygen therapy if necrotic.	Every 12–24 hours until infection controlled.

Key Consideration:
"The choice of disinfectant must balance efficacy against cytotoxicity. For example, while hydrogen peroxide is effective against biofilm, its oxidative damage to healthy tissue limits its use to necrotic debris removal."

Sterile Techniques in Surgical Wound Disinfection

Surgical environments employ multi-layered sterile techniques to minimize infection risk, combining preoperative skin preparation, intraoperative antisepsis, and postoperative wound care. The following methods are standardized in operating rooms and critical care settings:

1. Preoperative Skin Preparation Solutions
The skin’s microbial flora is




Emerging Technologies and Innovations in Wound Disinfection

Advancements in wound care have shifted from reliance on traditional antimicrobials to the integration of cutting-edge technologies that enhance efficacy, reduce toxicity, and enable real-time monitoring. Novel agents such as antimicrobial peptides (AMPs), bacteriophages, and quorum sensing inhibitors are being explored for their targeted mechanisms, while nanotechnology and smart dressings represent paradigm shifts in infection prevention. Concurrently, artificial intelligence (AI) and machine learning (ML) are revolutionizing personalized wound management by analyzing microbial profiles and genetic predispositions to optimize disinfection protocols. These innovations address critical gaps in conventional treatments, including antimicrobial resistance (AMR) and delayed infection detection.

The evolution of wound disinfection technologies reflects a convergence of biomaterials science, microbiology, and computational biology. Below, the principles of next-generation antimicrobial agents are examined, followed by an assessment of nanotechnology’s dual role in wound healing and infection control. A chronological overview of key milestones traces the progression from antibiotic discovery to AI-driven diagnostics, while the application of ML in predictive analytics is detailed to illustrate its transformative potential in clinical workflows.


Novel Antimicrobial Agents: Mechanisms and Comparative Advantages

Emerging antimicrobial agents leverage unique biological or chemical properties to overcome limitations of traditional disinfectants, such as broad-spectrum toxicity, resistance development, and insufficient penetration in biofilm-laden wounds. These agents include:

- Antimicrobial Peptides (AMPs)
AMPs are naturally occurring or synthetically engineered peptides (10–50 amino acids) that disrupt microbial membranes or inhibit essential cellular processes. Their advantages include:


20. Broad-spectrum activity: Effective against Gram-positive/negative bacteria, fungi, and enveloped viruses.
21. Low resistance potential: Multiple targets reduce selective pressure for resistance.
22. Selective toxicity: Disrupt microbial membranes while sparing mammalian cells via charge and lipid composition differences.
23. Synergistic effects: Combinations with conventional antibiotics (e.g., AMPs + rifampin) enhance efficacy against Pseudomonas aeruginosa biofilms.
24. Example: LL-37 (human cathelicidin) and dermaseptin (frog-derived) are in preclinical trials for chronic wound applications.

- Quorum Sensing Inhibitors (QSIs)
QSIs disrupt bacterial communication systems that regulate virulence factor production, biofilm formation, and antibiotic resistance. Mechanisms include:


25. Signal molecule analogs: Mimic acyl-homoserine lactones (AHLs) to block P. aeruginosa quorum sensing (e.g., furanones from red algae).
26. Enzyme inhibitors: Target AHL synthases or degradases (e.g., AiiA lactonase).
27. RNA interference (RNAi): Silences quorum sensing genes via small interfering RNAs (siRNAs).
28. Clinical relevance: Reduces biofilm-associated infections (e.g., Staphylococcus aureus in diabetic ulcers) without promoting resistance.

- Bacteriophages (Phage Therapy)
Bacteriophages—viruses that infect and lyse specific bacteria—offer targeted therapy with:


29. Narrow-spectrum precision: Phages like T4 or ΦKZ are tailored to pathogens (e.g., E. coli, S. aureus).
30. Biofilm penetration: Enzymes (e.g., depolymerases) disrupt extracellular polymeric substances (EPS).
31. Synergy with antibiotics: Phages enhance antibiotic efficacy by reducing bacterial load (e.g., phage + tobramycin for P. aeruginosa).
32. Challenges: Immunogenicity, phage resistance, and regulatory hurdles (e.g., FDA’s 2017 approval of SB-100 for P. aeruginosa infections).

Nanotechnology in Wound Healing and Disinfection

Nanotechnology integrates antimicrobial properties with wound healing by delivering active agents at the nanoscale, improving bioavailability and controlled release. Key applications include:


Nanomaterials exploit their high surface-area-to-volume ratio to enhance antimicrobial efficacy while enabling tissue regeneration. Silver nanoparticles (AgNPs), zinc oxide (ZnO), and titanium dioxide (TiO₂) generate reactive oxygen species (ROS) or disrupt microbial membranes. However, challenges such as cytotoxicity, long-term biocompatibility, and aggregation limit their clinical translation.

33. Mechanisms of Action
34. Metal-based nanoparticles (AgNPs, ZnO, CuO): Release metal ions (Ag⁺, Zn²⁺) that bind to thiol groups in proteins/DNA, inducing oxidative stress.
35. Carbon-based nanomaterials (graphene oxide, carbon nanotubes): Physically disrupt microbial membranes via sharp edges or π-π stacking interactions.
36. Polymeric nanoparticles (PLGA, chitosan): Encapsulate antibiotics (e.g., vancomycin) for sustained release, reducing systemic toxicity.
37. Magnetic nanoparticles (Fe₃O₄): Enable targeted delivery via external magnetic fields (e.g., for deep tissue infections).

- Wound Dressing Applications


38. Nano-coated dressings: Incorporate AgNPs into hydrogels (e.g., Aquacel Ag) to release ions over 7 days, reducing S. aureus colonization by 99%.
39. Smart nanofibers: Electrospun fibers with ZnO nanoparticles release antimicrobials in response to pH changes (e.g., acidic wound environments).
40. Nanocomposite films: Combine chitosan with TiO₂ for dual antimicrobial and hemostatic effects (e.g., Celox Nanoclay).

- Challenges and Future Directions


41. Toxicity: AgNPs and ZnO may induce oxidative damage in keratinocytes at high doses (LD₅₀ > 100 µg/mL in vitro).
42. Biodegradability: Non-biodegradable nanoparticles (e.g., carbon nanotubes) risk long-term tissue accumulation.
43. Standardization: Lack of consensus on nanoparticle size, shape, and surface functionalization for regulatory approval.
44. Emerging solutions: Biodegradable silica nanoparticles or peptide-functionalized nanocarriers to mitigate toxicity.

Timeline of Key Milestones in Wound Disinfection Technology

The progression of wound disinfection technologies reflects advancements in microbiology, materials science, and digital health. Below is a chronological overview of pivotal developments:


Year	Milestone	Impact	Key Agents/Technologies
1928	Discovery of penicillin (Fleming)	First systemic antibiotic; revolutionized surgical wound care.	Penicillin G
1940s	Sulfanilamide and broad-spectrum antibiotics (e.g., tetracyclines)	Reduced postoperative infections; emergence of AMR.	Chloramphenicol, streptomycin
1960s	Topical antiseptics (iodine, chlorhexidine)	Standardized preoperative skin preparation.	Povidone-iodine, chlorhexidine gluconate
1980s	Silver sulfadiazine for burn wounds	First FDA-approved silver-based antimicrobial dressing.	Silver sulfadiazine (Silvadene®)
2000s	Hydrogel and foam dressings with controlled release	Improved moisture balance and antibiotic delivery.	Hydrofera Blue, Acticoat (AgNPs)
2010s	Antimicrobial peptides (AMPs) in clinical trials	Targeted therapy with low resistance potential.	Pexiganan (topical AMP for diabetic foot ulcers)
2015	First FDA-approved phage therapy (SB-100)	Reintroduction of phage therapy for P. aeruginosa infections.	ΦKZ (SB-100)
2018	Smart dressings with biosensors (e.g., colorimetric indicators)	Real-time infection monitoring The landscape of wound disinfection reflects a dynamic interplay between established medical practices and innovative solutions, each tailored to specific clinical needs. From the precise dilution ratios of pharmaceutical agents to the antimicrobial synergy of honey-based therapies, the choice of disinfectant must align with scientific rigor and patient safety. Emerging technologies, including AI-driven diagnostics and nanoscale antimicrobials, promise to further refine personalized wound care, though their integration demands rigorous validation to address challenges like toxicity and long-term efficacy. Ultimately, the most effective disinfection strategy combines a deep understanding of microbial pathophysiology with adaptive protocols that prioritize both infection control and optimal tissue regeneration. FAQ what is used to clean open wounds? Q: What are the best substances or methods to clean an open wound safely? what to use to clean open wounds on dogs? Q: What is safe and effective to clean open wounds on dogs at home? what do doctors use to clean open wounds? Q: What solutions or tools do doctors typically use to clean open wounds during treatment? what do hospitals use to clean open wounds? Q: What disinfectants or cleaning agents do hospitals use for treating open wounds? how do you disinfect an open wound? Q: What steps should I follow to properly disinfect an open wound at home? what do you disinfect a wound with? Q: What common household or medical items can I use to disinfect a wound? antimicrobial agents infection prevention medical-grade treatments natural wound care wound disinfection Leave a Comment Name Comment Post Comment Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.